Insiders · LTGO

Sanofi

10% owner at Latigo Biotherapeutics, Inc. (LTGO) since August 2026

Sanofi has filed 9 insider reports with the SEC since July 2021, as 10% owner at Latigo Biotherapeutics, Inc. (LTGO), 10% owner at Attovia Therapeutics, Inc. (ATTO) and 10% owner at MeiraGTx Holdings plc (MGTX) and at 2 more companies. In the last 12 months Sanofi bought $5.1M of stock on the open market. The latest filing, on August 12, 2026, reports conversion of a derivative at Latigo Biotherapeutics, Inc. (LTGO).

Filings
9
Companies
5
Bought on market
$2.74B
Sold on market
None

Companies where Sanofi is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Latigo Biotherapeutics, Inc. logo
LTGO
Latigo Biotherapeutics, Inc.
10% ownersince August 2026$13.24Aug 12, 2026
Attovia Therapeutics, Inc. logo
ATTO
Attovia Therapeutics, Inc.
10% ownersince August 2026$5.1M$17.00$15.58-8.4%Aug 7, 2026
MeiraGTx Holdings plc logo
MGTX
MeiraGTx Holdings plc
10% ownersince August 2024$8.14Aug 13, 2024
Translate Bio, Inc. logo
TBIO
Translate Bio, Inc.
10% ownersince August 202175,668,031$2.74B$38.00Sep 14, 2021
Icosavax, Inc. logo
SNY
Icosavax, Inc.
10% ownersince July 2021$1M$15.00$46.06+207%Aug 3, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Sanofi with

Other insiders at the same companies

Questions about Sanofi

What is Sanofi's role at Latigo Biotherapeutics, Inc.?
Sanofi reports to the SEC as 10% owner at Latigo Biotherapeutics, Inc. (LTGO), according to the latest filing on August 12, 2026. Sanofi has also filed as 10% owner at Attovia Therapeutics, Inc. (ATTO), 10% owner at MeiraGTx Holdings plc (MGTX), 10% owner at Translate Bio, Inc. (TBIO) and 10% owner at Icosavax, Inc. (SNY).
How many shares does Sanofi own?
After the latest filing that states it, Sanofi directly owned 75,668,031 shares of Translate Bio, Inc. (TBIO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Sanofi bought or sold stock recently?
The most recent open-market purchase was on August 6, 2026: bought 300,000 shares of Attovia Therapeutics, Inc. (ATTO) for $5.1M at an average of $17.00.
How do I get alerts when Sanofi files?
Follow Sanofi on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Sanofi (SEC CIK 0001121404). Totals count each trade once, skipping amendments whose original is on file, from Jul 29, 2021 on. View on SEC EDGAR · Get this as JSON